Ifosfamide/mesna kit side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Ifosfamide/mesna kit. Common side effects include abasia among females and neutropenia among males.

The phase IV clinical study is created by eHealthMe based on 4 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 26, 2022

4 people who take Ifosfamide/Mesna Kit and have side effects are studied.


What is Ifosfamide/Mesna Kit?

Ifosfamide/mesna kit has active ingredients of ifosfamide; mesna. eHealthMe is studying from 7 Ifosfamide/mesna kit users for its effectiveness, alternative drugs and more.

Number of Ifosfamide/mesna kit reports submitted per year:

Ifosfamide/mesna kit side effects.

Ifosfamide/Mesna Kit side effects by time on the drug*:

< 1 month:

  1. Abasia (inability to walk)
  2. Neutropenia (an abnormally low number of neutrophils)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Septic shock (shock due to blood infection)

Ifosfamide/Mesna Kit side effects by gender *:

female:

  1. Abasia (inability to walk)
  2. Coma (state of unconsciousness lasting more than six hours)

male:

  1. Neutropenia (an abnormally low number of neutrophils)

Ifosfamide/Mesna Kit side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

  1. Coma (state of unconsciousness lasting more than six hours)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abasia (inability to walk)
  2. Neutropenia (an abnormally low number of neutrophils)

* Approximation only. Some reports may have incomplete information.

Do you take Ifosfamide/mesna kit?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on ifosfamide; mesna (the active ingredients of Ifosfamide/mesna kit) and Ifosfamide/mesna kit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Ifosfamide/mesna kit:

All Ifosfamide/mesna kit side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: